MDLN (Medline) Other Stockholders Equity: $0 Mil (As of Mar. 2026)


MDLN Medline Inc MDLN
16 GF Score
Price $40.29
! 3 Warning Signs
View Full Analysis

What is Medline Other Stockholders Equity?

Medline MDLN -6.30% 16 Other Stockholders Equity is $0 Mil as of Mar. 2026. GuruFocus rates MDLN with a GF Score™ of 16/100. The stock has 3 warning signs investors should review.

Medline's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $0 Mil.

Medline's quarterly Other Stockholders Equity declined from Sep. 2025 ($75 Mil) to Dec. 2025 ($0 Mil) but then stayed the same from Dec. 2025 ($0 Mil) to Mar. 2026 ($0 Mil).

Medline's annual Other Stockholders Equity increased from Dec. 2023 ($-133 Mil) to Dec. 2024 ($366 Mil) but then declined from Dec. 2024 ($366 Mil) to Dec. 2025 ($0 Mil).

Medline Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Medline's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medline Other Stockholders Equity Chart

Medline Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
0.00 -133.00 366.00 0.00

Medline Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only 0.00 66.00 75.00 0.00 0.00
MDLN
16GF Score
Medline Inc MDLN
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medline Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0 Mil mean?
Medline (MDLN) has a Other Stockholders Equity of $0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medline and its competitors.
Is Medline's Other Stockholders Equity too high?
Medline's current Other Stockholders Equity is $0 Mil. Overall, Medline has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Medline's Other Stockholders Equity compare to RMD and WST?
Medline's Other Stockholders Equity of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Medline and its competitors. Medline's current Other Stockholders Equity is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medline stock overvalued right now?
Medline (MDLN) has a current Other Stockholders Equity of $0 Mil. The current Other Stockholders Equity is $0 Mil. Medline's overall GF Score™ is 16/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Medline (MDLN), the current Other Stockholders Equity is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medline Business Description

Other Exchanges L10:Germany
Address 3 Lakes Drive, Northfield, IL, USA, 60093
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
16GF Score

Get the complete analysis for MDLN

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.29
Price